出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年2月
光学画像市場 : 製品 (カメラ、レンズ)、技術 (OCT、HIS、NIR、PAT)、治療領域 (眼科、皮膚科、腫瘍学)、用途 (病理学、術中)、エンドユーザー (病院、研究所) – 2027年までの世界予測
Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) – Global Forecast to 2027
| ページ数 | 250 |
| 図表数 | 263 |
| 種別 | 英文調査報告書 |
| 価格 |
The global optical imaging market is projected to reach USD 2.9 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.5%. The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2019 and January 2023. Players in the global optical imaging market have employed various strategies to expand their global footprint and increase their market shares such as agreements, divestitures, expansions, and acquisitions.
“Software accounted for the fastest growing segment in the optical imaging product market”
Efficient visualization and quantitative evaluation of volumetric data gathered during the imaging process makes it an essential subsegment in this market. Continuous upgrades in existing systems is possible due to high tech software solutions that allows improved performance and enables precise decision making. Major players also market separate software solutions to provide enhanced capabilities to prior installed systems at end user site and ensure cost efficiency. Thus, it is the fastest growing segment in this market.
“Intra-operative accounted for the fastest growing segment in the optical imaging application market”
Increasing need for reproducibility & accuracy in medical processes and rising labor costs, propelled the intra-operative market growth. Moreover, various government bodies have extended their support through investments and funds, promoting research-related activities in this market. Support during surgical workflow and eases surgical decisions, are the major reasons for improved adoption of optical imaging systems in intraoperative sector.
“Optical coherence tomography segment accounted for the largest share in the optical imaging market”
This technique accounted for the largest share in the techniques segment owing to its implementation in numerous application areas and rising demand for use in dentistry, gynecology, urology, and others. Increased development initiative by players to launch new OCT systems is also influencing the market growth. Increased need of end users to adopt technologically superior systems such as opto-acoustic systems that is powered with the technological ability of optical coherence tomography and photoacoustic and the rising demand for safer, accurate, and precise systems have enhanced the market growth.
“North America to dominate the optical imaging market during the forecast period”
The optical imaging market in North America dominated the optical imaging market in the forecast period. The largest share of North America in the global market is attributed to the rise in cancer cases and increased research to develop advanced technology for neurological imaging. Presence of major optical imaging players and increase in geriatric population are the factors influencing the market growth. Additionally, the presence of many biopharmaceutical companies and research laboratories engaged in preclinical studies as well as the development of therapeutics in the US region of North America, also boosted the overall regional market.
Key Market Players:
The prominent players in the optical imaging market include Carl Zeiss Meditec AG (Germany), Abbott (US), Topcon Corporation (Japan), Canon Inc. (Japan), PerkinElmer, Inc. (US), Koninklijke Philips N.V. (Netherlands), Heidelberg Engineering (US), Leica Microsystems (Germany), Headwall Photonics, Inc. (US), Visionix (US), Optical Imaging Ltd. (Israel), Optos (Scotland), Wasatch Photonics (Utah), ArcScan Inc.(US), DermaLumics (Spain), Cylite Pty Ltd. (Australia), MOPTIM (Guangdong), Michelson Diagnostics Ltd. (England), Thorlabs (US), Hamamatsu Photonics K.K. (Japan), iTheraMedical (Germany), Kibero (Germany), Seno Medical (US), Aspectus Imaging (Germany), and Agfa-Gevaert N.V (Belgium).
A breakdown of the primary participants for the optical imaging market (By Supply Side) referred to for this report is provided below:
• By Company Type: Tier 1–42%, Tier 2–31%, and Tier 3–27%
• By Designation: C-level–30%, Director Level–45%, and Others–25%
• By Region: North America–42%, Europe–28%, Asia Pacific–19%, RoW- 11%
Research Coverage:
The market study covers the optical imaging market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by application, by end user, by techniques, by therapeutic area, and by region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the optical imaging market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
目次
1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION & SCOPE 34
1.2.1 INCLUSIONS & EXCLUSIONS 34
1.3 MARKETS COVERED 35
FIGURE 1 OPTICAL IMAGING MARKET SEGMENTATION 35
1.3.1 YEARS CONSIDERED 36
1.4 CURRENCY 36
1.5 STAKEHOLDERS 36
1.6 LIMITATIONS 37
1.7 SUMMARY OF CHANGES 37
1.8 IMPACT OF RECESSION 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH APPROACH 38
FIGURE 2 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 39
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
FIGURE 3 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 42
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 42
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 44
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION 45
FIGURE 9 COUNTRY-LEVEL ANALYSIS OF OPTICAL IMAGING MARKET 45
FIGURE 10 APPROACH 4: TOP-DOWN APPROACH 46
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF OPTICAL IMAGING MARKET 48
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 49
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 49
2.4 MARKET SHARE ASSUMPTIONS 50
2.5 ASSUMPTIONS 50
3 EXECUTIVE SUMMARY 51
FIGURE 14 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 51
FIGURE 15 OPTICAL IMAGING MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 52
FIGURE 16 OPTICAL IMAGING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 52
FIGURE 17 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION) 53
FIGURE 18 OPTICAL IMAGING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 53
FIGURE 19 GEOGRAPHICAL SNAPSHOT OF OPTICAL IMAGING MARKET 54
4 PREMIUM INSIGHTS 55
4.1 OPTICAL IMAGING MARKET OVERVIEW 55
FIGURE 20 INCREASING PREVALENCE OF EYE DISORDERS TO DRIVE GROWTH IN OPTICAL IMAGING MARKET 55
4.2 NORTH AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION AND COUNTRY 56
FIGURE 21 PATHOLOGICAL IMAGING SYSTEMS DOMINATED MARKET IN 2021 56
4.3 REGIONAL MIX: OPTICAL IMAGING MARKET 56
FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 56
4.4 OPTICAL IMAGING MARKET: REGIONAL SNAPSHOT 57
FIGURE 23 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
FIGURE 24 OPTICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
5.2.1 DRIVERS 59
5.2.1.1 Growing geriatric population and subsequent increase in prevalence of eye disorders 59
FIGURE 25 PERCENTAGE OF GERIATRIC POPULATION, BY REGION 59
TABLE 1 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2013 VS. 2020 VS. 2040 (MILLION) 60
5.2.1.2 Technological innovations 60
5.2.1.3 Growing application areas of optical imaging techniques 61
5.2.1.4 Growing need to minimize use of radiation technologies 61
TABLE 2 KEY MARKET DRIVERS 62
5.2.2 RESTRAINTS 62
5.2.2.1 Reimbursement challenges 62
5.2.2.2 Lack of skilled operators 62
TABLE 3 KEY MARKET RESTRAINTS 63
5.2.3 OPPORTUNITIES 63
5.2.3.1 Expansion and market penetration opportunities in emerging economies 63
TABLE 4 GERIATRIC POPULATION TREND IN DEVELOPING REGIONS, 2020 AND 2060 64
5.2.3.2 Growing applications in pharmaceutical & biotechnology research 64
TABLE 5 KEY MARKET OPPORTUNITIES 65
5.2.4 CHALLENGES 65
5.2.4.1 Sustainability of small and medium-sized players 65
5.2.4.2 High cost of optical imaging procedures and extensive data requirements 65
TABLE 6 KEY MARKET CHALLENGES 66
5.3 PORTER’S FIVE FORCES ANALYSIS 66
FIGURE 26 PORTER’S FIVE FORCES ANALYSIS 66
TABLE 7 OPTICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 67
5.3.1 THREAT FROM NEW ENTRANTS 67
5.3.2 THREAT FROM SUBSTITUTES 68
5.3.3 BARGAINING POWER OF SUPPLIERS 68
5.3.4 BARGAINING POWER OF BUYERS 68
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 68
5.4 VALUE CHAIN ANALYSIS 69
FIGURE 27 OPTICAL IMAGING MARKET: VALUE CHAIN ANALYSIS 69
5.5 SUPPLY CHAIN ANALYSIS 69
FIGURE 28 OPTICAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS 71
5.6 REGULATORY ANALYSIS 71
TABLE 8 STRINGENCY OF REGULATIONS FOR OPTICAL IMAGING PRODUCTS,
BY REGION 71
5.6.1 NORTH AMERICA 71
5.6.1.1 US 71
TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION 72
5.6.1.2 Canada 72
TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 72
5.6.2 EUROPE 73
5.6.3 ASIA PACIFIC 73
5.6.3.1 Japan 73
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 74
5.6.3.2 China 74
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 74
5.6.3.3 India 75
5.7 PATENT ANALYSIS 75
5.8 PRICING ANALYSIS 75
5.9 TRADE DATA 76
5.9.1 US 76
TABLE 13 TOP SUPPLIERS AND BUYERS OF OPTICAL IMAGING SYSTEMS IN US, 2020 76
5.9.2 CHINA 76
5.9.3 UK 77
5.9.4 INDIA 77
6 OPTICAL IMAGING MARKET, BY PRODUCT 78
6.1 INTRODUCTION 79
TABLE 14 GLOBAL OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 79
6.2 IMAGING SYSTEMS 79
TABLE 15 IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 80
TABLE 16 IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
6.2.1 OPTICAL IMAGING SYSTEMS 81
6.2.1.1 Growing need for high-resolution imaging in ophthalmology to drive market growth 81
TABLE 17 KEY OPTICAL IMAGING SYSTEMS 82
TABLE 18 OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
6.2.2 SPECTRAL IMAGING SYSTEMS 83
6.2.2.1 Growing need for advanced imaging techniques to promote growth 83
TABLE 19 SPECTRAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
6.3 CAMERAS 84
6.3.1 BENEFITS SUCH AS BETTER SENSITIVITY AND HIGH-RESOLUTION IMAGING CAPABILITIES TO DRIVE DEMAND FOR CAMERAS 84
TABLE 20 OPTICAL IMAGING CAMERAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
6.4 SOFTWARE 85
6.4.1 GROWING DEMAND FOR ADVANCED AND OPTIMIZED OPTICAL IMAGING SOFTWARE TO SUPPORT GROWTH 85
TABLE 21 OPTICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86
6.5 LENSES 86
6.5.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGING TO BOOST DEMAND FOR LENSES 86
TABLE 22 OPTICAL IMAGING LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.6 ILLUMINATION SYSTEMS 87
6.6.1 GROWING DEMAND FOR NON-IONIZING AND RADIATION-FREE TECHNIQUES TO BOOST MARKET GROWTH 87
TABLE 23 OPTICAL IMAGING ILLUMINATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88
6.7 OTHER PRODUCTS 88
TABLE 24 OTHER OPTICAL IMAGING PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
7 OPTICAL IMAGING MARKET, BY TECHNIQUE 90
7.1 INTRODUCTION 91
TABLE 25 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 91
7.2 OPTICAL COHERENCE TOMOGRAPHY (OCT) 91
7.2.1 RISING INNOVATIONS IN OCT TO DRIVE MARKET GROWTH 91
TABLE 26 OPTICAL COHERENCE TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.3 NEAR-INFRARED SPECTROSCOPY (NIRS) 93
7.3.1 INCREASING FUNDS BY GOVERNMENT ORGANIZATIONS AND UNIVERSITIES FOR R&D TO PROMOTE MARKET GROWTH 93
TABLE 27 NEAR-INFRARED SPECTROSCOPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.4 HYPERSPECTRAL IMAGING (HSI) 94
7.4.1 GROWING INDUSTRIAL APPLICATIONS OF HYPERSPECTRAL IMAGING TO BOOST GROWTH 94
TABLE 28 HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.5 PHOTOACOUSTIC TOMOGRAPHY (PAT) 95
7.5.1 RISING CANCER CASES AND BROAD APPLICATIONS IN RESEARCH AND CLINICAL CARE TO SUPPORT GROWTH 95
TABLE 29 PHOTOACOUSTIC TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
8 OPTICAL IMAGING MARKET, BY APPLICATION 97
8.1 INTRODUCTION 98
TABLE 30 OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98
8.2 PATHOLOGICAL IMAGING 98
8.2.1 LOW OPERATIONAL COSTS AND RELATIVE EASE OF USE TO DRIVE GROWTH 98
TABLE 31 PATHOLOGICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
8.3 INTRA-OPERATIVE IMAGING 99
8.3.1 RISING LABOR COSTS AND INCREASING NEED FOR ACCURACY IN MEDICAL PROCESSES TO DRIVE MARKET 99
TABLE 32 INTRA-OPERATIVE IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
9 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA 101
9.1 INTRODUCTION 102
TABLE 33 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 102
9.2 OPHTHALMOLOGY 102
9.2.1 GROWING NUMBER OF OPHTHALMIC PROCEDURES TO PROPEL MARKET 102
TABLE 34 OPTICAL IMAGING MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 103
9.3 ONCOLOGY 104
9.3.1 GROWING PRECLINICAL DRUG DEVELOPMENT RESEARCH ON CANCER TO PROMOTE GROWTH 104
TABLE 35 OPTICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 105
9.4 CARDIOLOGY 105
9.4.1 ADVANCED INNOVATIONS IN OCT TECHNIQUES FOR CARDIOLOGY APPLICATIONS TO BOOST MARKET 105
TABLE 36 OPTICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.5 DERMATOLOGY 106
9.5.1 GROWING INCIDENCE OF SKIN CANCER TO FUEL DEMAND FOR OPTICAL IMAGING 106
TABLE 37 OPTICAL IMAGING MARKET FOR DERMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 107
9.6 NEUROLOGY 107
9.6.1 LOW COST AND GROWING UTILIZATION OF OPTICAL IMAGING TECHNIQUES TO PROMOTE GROWTH 107
TABLE 38 OPTICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 108
9.7 OTHER THERAPEUTIC AREAS 109
TABLE 39 OPTICAL IMAGING MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2020–2027 (USD MILLION) 109
10 OPTICAL IMAGING MARKET, BY END USER 110
10.1 INTRODUCTION 111
TABLE 40 OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 111
10.2 HOSPITALS & CLINICS 111
10.2.1 INCREASING CLINICAL APPLICATIONS OF OPTICAL IMAGING TECHNIQUES IN HOSPITALS TO DRIVE MARKET 111
TABLE 41 OPTICAL IMAGING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 112
10.3 RESEARCH LABORATORIES 113
10.3.1 AVAILABILITY OF RESEARCH FUNDING FROM PRIVATE AND GOVERNMENT ORGANIZATIONS TO PROMOTE GROWTH 113
TABLE 42 OPTICAL IMAGING MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 114
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 114
10.4.1 GREATER UTILIZATION OF OPTICAL IMAGING TECHNIQUES IN DRUG DISCOVERY PROCESSES TO SUPPORT MARKET 114
TABLE 43 OPTICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 116
11 OPTICAL IMAGING MARKET, BY REGION 117
11.1 INTRODUCTION 118
FIGURE 29 OPTICAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 118
TABLE 44 OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
11.2 NORTH AMERICA 119
11.2.1 NORTH AMERICA: RECESSION IMPACT 120
FIGURE 30 NORTH AMERICA: OPTICAL IMAGING MARKET SNAPSHOT 120
TABLE 45 NORTH AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 46 NORTH AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121
TABLE 47 NORTH AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 48 NORTH AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 49 NORTH AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 122
TABLE 50 NORTH AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122
TABLE 51 NORTH AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 123
11.2.2 US 123
11.2.2.1 Presence of several large hospitals & health systems to increase number of imaging & diagnostic procedures in country 123
TABLE 52 US: MACROECONOMIC INDICATORS 124
TABLE 53 US: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 124
TABLE 54 US: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 55 US: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 56 US: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 125
TABLE 57 US: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 125
TABLE 58 US: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 126
11.2.3 CANADA 126
11.2.3.1 Availability of research funding to drive growth 126
TABLE 59 CANADA: MACROECONOMIC INDICATORS 126
TABLE 60 CANADA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127
TABLE 61 CANADA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 62 CANADA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 127
TABLE 63 CANADA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 128
TABLE 64 CANADA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 65 CANADA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 128
11.3 EUROPE 129
11.3.1 EUROPE: RECESSION IMPACT 129
FIGURE 31 EUROPE: OPTICAL IMAGING MARKET SNAPSHOT 130
TABLE 66 EUROPE: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 67 EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 131
TABLE 68 EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 69 EUROPE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 70 EUROPE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 132
TABLE 71 EUROPE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 132
TABLE 72 EUROPE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 133
11.3.2 GERMANY 133
11.3.2.1 Robust healthcare spending to support market in Germany 133
TABLE 73 GERMANY: MACROECONOMIC INDICATORS 134
TABLE 74 GERMANY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 134
TABLE 75 GERMANY: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 76 GERMANY: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 135
TABLE 77 GERMANY: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 135
TABLE 78 GERMANY: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135
TABLE 79 GERMANY: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 136
11.3.3 FRANCE 136
11.3.3.1 Increasing healthcare expenditure and rising medical tourism in France to propel growth 136
TABLE 80 FRANCE: MACROECONOMIC INDICATORS 137
TABLE 81 FRANCE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 137
TABLE 82 FRANCE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 83 FRANCE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 138
TABLE 84 FRANCE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 138
TABLE 85 FRANCE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 138
TABLE 86 FRANCE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 139
11.3.4 UK 139
11.3.4.1 Growing adoption of optical imaging techniques and in vivo research applications to drive growth 139
TABLE 87 UK: MACROECONOMIC INDICATORS 140
TABLE 88 UK: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 140
TABLE 89 UK: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 90 UK: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 141
TABLE 91 UK: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 141
TABLE 92 UK: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 141
TABLE 93 UK: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 142
11.3.5 ITALY 142
11.3.5.1 Presence of major pharmaceutical & research institutes to drive market 142
TABLE 94 ITALY: MACROECONOMIC INDICATORS 143
TABLE 95 ITALY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 143
TABLE 96 ITALY: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 97 ITALY: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 144
TABLE 98 ITALY: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 144
TABLE 99 ITALY: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 144
TABLE 100 ITALY: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 145
11.3.6 SPAIN 145
11.3.6.1 Increasing development in biomedical sciences to drive growth 145
TABLE 101 SPAIN: MACROECONOMIC INDICATORS 146
TABLE 102 SPAIN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 146
TABLE 103 SPAIN: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 104 SPAIN: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 147
TABLE 105 SPAIN: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 147
TABLE 106 SPAIN: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147
TABLE 107 SPAIN: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 148
11.3.7 REST OF EUROPE 148
TABLE 108 SHARE OF GERIATRIC POPULATION (AGED 65 YEARS AND ABOVE) IN ROE COUNTRIES 149
TABLE 109 REST OF EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 149
TABLE 110 REST OF EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 111 REST OF EUROPE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 150
TABLE 112 REST OF EUROPE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 150
TABLE 113 REST OF EUROPE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 114 REST OF EUROPE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 151
11.4 ASIA PACIFIC 151
11.4.1 ASIA PACIFIC: RECESSION IMPACT 152
FIGURE 32 ASIA PACIFIC: OPTICAL IMAGING MARKET SNAPSHOT 152
TABLE 115 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 116 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 153
TABLE 117 ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 118 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 154
TABLE 119 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 154
TABLE 120 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 121 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 155
11.4.2 JAPAN 155
11.4.2.1 Established pharmaceutical & biotechnology research base to propel market 155
TABLE 122 JAPAN: MACROECONOMIC INDICATORS 156
TABLE 123 JAPAN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 156
TABLE 124 JAPAN: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 125 JAPAN: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 157
TABLE 126 JAPAN: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 157
TABLE 127 JAPAN: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 157
TABLE 128 JAPAN: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 158
11.4.3 CHINA 158
11.4.3.1 Presence of large population base and favorable initiatives undertaken by authorities to aid growth 158
TABLE 129 CHINA: MACROECONOMIC INDICATORS 159
TABLE 130 CHINA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 159
TABLE 131 CHINA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 132 CHINA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 160
TABLE 133 CHINA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 160
TABLE 134 CHINA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160
TABLE 135 CHINA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 161
11.4.4 INDIA 161
11.4.4.1 Rising adoption of advanced diagnostic imaging technologies by healthcare providers to boost market 161
TABLE 136 INDIA: MACROECONOMIC INDICATORS 162
TABLE 137 INDIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 162
TABLE 138 INDIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 139 INDIA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 163
TABLE 140 INDIA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 163
TABLE 141 INDIA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 163
TABLE 142 INDIA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 164
11.4.5 AUSTRALIA 164
11.4.5.1 Growing awareness of healthcare services and rising healthcare expenditure to support market 164
TABLE 143 AUSTRALIA: MACROECONOMIC INDICATORS 164
TABLE 144 AUSTRALIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 165
TABLE 145 AUSTRALIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 146 AUSTRALIA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 165
TABLE 147 AUSTRALIA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 166
TABLE 148 AUSTRALIA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 166
TABLE 149 AUSTRALIA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 166
11.4.6 SOUTH KOREA 167
11.4.6.1 Growing expenditure on improved healthcare services and rising geriatric population to propel growth 167
TABLE 150 SOUTH KOREA: MACROECONOMIC INDICATORS 167
TABLE 151 SOUTH KOREA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 167
TABLE 152 SOUTH KOREA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 153 SOUTH KOREA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 168
TABLE 154 SOUTH KOREA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 168
TABLE 155 OUTH KOREA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 169
TABLE 156 SOUTH KOREA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 169
11.4.7 REST OF ASIA PACIFIC 169
TABLE 157 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170
TABLE 158 REST OF ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 159 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 170
TABLE 160 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 171
TABLE 161 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 171
TABLE 162 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 171
11.5 LATIN AMERICA 172
11.5.1 LATIN AMERICA: RECESSION IMPACT 172
TABLE 163 LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 172
TABLE 164 LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 173
TABLE 165 LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 166 LATIN AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 167 LATIN AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 174
TABLE 168 LATIN AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 174
TABLE 169 LATIN AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 174
11.5.2 BRAZIL 175
11.5.2.1 Improved GDP expenditure on healthcare 175
TABLE 170 BRAZIL: MACROECONOMIC INDICATORS 175
TABLE 171 BRAZIL: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 175
TABLE 172 BRAZIL: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 173 BRAZIL: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 174 BRAZIL: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 176
TABLE 175 BRAZIL: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 177
TABLE 176 BRAZIL: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 177
11.5.3 REST OF LATIN AMERICA 177
TABLE 177 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 178
TABLE 178 REST OF LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 179 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 178
TABLE 180 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 179
TABLE 181 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 179
TABLE 182 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 179
11.6 MIDDLE EAST & AFRICA 180
11.6.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH 180
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 180
TABLE 183 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 181
TABLE 184 MIDDLE EAST & AFRICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 185 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 181
TABLE 186 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 182
TABLE 187 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 182
TABLE 188 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 182
12 COMPETITIVE LANDSCAPE 183
12.1 INTRODUCTION 183
FIGURE 33 KEY MARKET DEVELOPMENTS (JANUARY 2020 TO JANUARY 2023) 184
12.2 REVENUE SHARE ANALYSIS 185
FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET 185
12.3 MARKET SHARE ANALYSIS 186
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET, 2021 186
12.4 COMPANY EVALUATION QUADRANT 187
12.4.1 STARS 188
12.4.2 EMERGING LEADERS 188
12.4.3 PERVASIVE PLAYERS 188
12.4.4 PARTICIPANTS 188
FIGURE 36 OPTICAL IMAGING MARKET: GLOBAL COMPANY EVALUATION QUADRANT 189
12.5 START-UP/SME EVALUATION QUADRANT 190
12.5.1 PROGRESSIVE COMPANIES 190
12.5.2 STARTING BLOCKS 190
12.5.3 RESPONSIVE COMPANIES 190
12.5.4 DYNAMIC COMPANIES 190
FIGURE 37 OPTICAL IMAGING MARKET: GLOBAL START-UP/SME MATRIX 191
12.6 COMPETITIVE BENCHMARKING 192
12.6.1 COMPANY FOOTPRINT FOR KEY PLAYERS 192
12.6.2 PRODUCT FOOTPRINT 193
12.6.3 TECHNIQUE FOOTPRINT 194
12.6.4 THERAPEUTIC AREA FOOTPRINT 195
12.6.5 REGIONAL FOOTPRINT 196
12.7 GEOGRAPHIC FOOTPRINT OF KEY PLAYERS 197
FIGURE 38 GEOGRAPHIC REVENUE MIX: KEY PLAYERS 197
12.8 COMPETITIVE SITUATION AND TRENDS 197
12.8.1 PRODUCT LAUNCHES & APPROVALS 198
TABLE 189 OPTICAL IMAGING MARKET: PRODUCT LAUNCHES (JANUARY 2019 TO JANUARY 2023) 198
12.8.2 DEALS 198
TABLE 190 OPTICAL IMAGING MARKET: DEALS(JANUARY 2019 TO JANUARY 2023) 198
12.8.3 OTHER DEVELOPMENTS 199
TABLE 191 OPTICAL IMAGING MARKET: OTHER DEVELOPMENTS (JANUARY 2019 TO JANUARY 2023) 199
13 COMPANY PROFILES 200
13.1 KEY PLAYERS 200
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 CARL ZEISS MEDITEC AG 200
TABLE 192 CARL ZEISS MEDITEC AG: BUSINESS OVERVIEW 200
FIGURE 39 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021) 201
13.1.2 TOPCON CORPORATION 204
TABLE 193 TOPCON CORPORATION: BUSINESS OVERVIEW 204
FIGURE 40 TOPCON CORPORATION: COMPANY SNAPSHOT (2021) 205
13.1.3 CANON INC. 207
TABLE 194 CANON INC.: BUSINESS OVERVIEW 207
FIGURE 41 CANON INC.: COMPANY SNAPSHOT (2021) 208
13.1.4 ABBOTT LABORATORIES INC. 211
TABLE 195 ABBOTT LABORATORIES: BUSINESS OVERVIEW 211
FIGURE 42 ABBOTT LABORATORIES INC.: COMPANY SNAPSHOT (2021) 212
13.1.5 KONINKLIJKE PHILIPS N.V. 215
TABLE 196 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 215
FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021) 216
13.1.6 PERKINELMER, INC. 218
TABLE 197 PERKINELMER, INC.: BUSINESS OVERVIEW 218
FIGURE 44 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 219
13.1.7 LEICA MICROSYSTEMS (DANAHER CORPORATION) 220
TABLE 198 LEICA MICROSYSTEMS (DANAHER CORPORATION): BUSINESS OVERVIEW 220
FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 221
13.1.8 AGFA-GEVAERT N.V. 223
TABLE 199 AGFA-GEVAERT N.V.: BUSINESS OVERVIEW 223
FIGURE 46 AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2021) 224
13.1.9 HAMAMATSU PHOTONICS K.K. 225
TABLE 200 HAMAMATSU PHOTONICS K.K.: BUSINESS OVERVIEW 225
FIGURE 47 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2021) 225
13.2 OTHER PLAYERS 227
13.2.1 HEIDELBERG ENGINEERING, INC. 227
TABLE 201 HEIDELBERG ENGINEERING, INC.: BUSINESS OVERVIEW 227
13.2.2 HEADWALL PHOTONICS, INC. 229
TABLE 202 HEADWALL PHOTONICS, INC.: BUSINESS OVERVIEW 229
13.2.3 VISIONIX (FORMERLY LUNEAU TECHNOLOGY USA & OPTOVUE INC.) 231
TABLE 203 VISIONIX: BUSINESS OVERVIEW 231
13.2.4 OPTICAL IMAGING LTD. 233
TABLE 204 OPTICAL IMAGING LTD.: BUSINESS OVERVIEW 233
13.2.5 OPTOS 234
TABLE 205 OPTOS: BUSINESS OVERVIEW 234
13.2.6 WASATCH PHOTONICS 235
TABLE 206 WASATCH PHOTONICS: BUSINESS OVERVIEW 235
13.2.7 ARCSCAN INC. 236
TABLE 207 ARCSCAN INC.: BUSINESS OVERVIEW 236
13.2.8 DERMALUMICS 237
TABLE 208 DERMALUMICS: BUSINESS OVERVIEW 237
13.2.9 CYLITE PTY LTD. 238
TABLE 209 CYLITE PTY LTD.: BUSINESS OVERVIEW 238
13.2.10 MOPTIM 239
TABLE 210 MOPTIM: BUSINESS OVERVIEW 239
13.2.11 MICHELSON DIAGNOSTICS LTD. 240
TABLE 211 MICHELSON DIAGNOSTICS LTD.: BUSINESS OVERVIEW 240
13.2.12 THORLABS 241
TABLE 212 THORLABS: BUSINESS OVERVIEW 241
13.2.13 ITHERAMEDICAL 242
TABLE 213 ITHERAMEDICAL: BUSINESS OVERVIEW 242
13.2.14 KIBERO 244
TABLE 214 KIBERO: BUSINESS OVERVIEW 244
13.2.15 SENO MEDICAL 246
TABLE 215 SENO MEDICAL: BUSINESS OVERVIEW 246
13.2.16 ASPECTUS IMAGING 248
TABLE 216 ASPECTUS IMAGING: BUSINESS OVERVIEW 248
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 249
14.1 INSIGHTS FROM INDUSTRY EXPERTS 249
14.2 DISCUSSION GUIDE 250
14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 255
14.4 CUSTOMIZATION OPTIONS 257
14.5 RELATED REPORTS 257
14.6 AUTHOR DETAILS 258